从科学里程碑中创造价值

世界一流的生物科学发现,为全球患者、医院和医疗保健行业人士供需日常对药物和医疗设备的基础需求。

对于具有创造无疾病世界的潜力创新的需求,比以往任何时候都更加紧迫。

在iQ集团,我们的专家发现、投资和开发改变人类命运的生物科学资产。

iQ集团在澳大利亚的两家交易所有四家上市公司,拥有私人银行、财务规划和股票分析方面的专业知识。iQ集团正在为全球医疗市场带来独特的创新机遇。

联系我们,或在下方注册获取资讯。

上市公司

国际的

GBS Inc. is developing and launching diagnostic tests urgently needed to help eradicate COVID-19 and change the lives of people living with diabetes. NASDAQ:GBS

澳大利亚

iQX raises the capital needed to fund scientific development of life science assets. NSX:iQX
(Formerly iQnovate) The iQ Group Global Ltd. is a team of scientific experts that manage asset IP, and create asset development strategies. NSX:iQG
iQ3 provides corporate advisory and deal structuring services for the life science industry. ASX:iQ3
Farmaforce Ltd provides best in class sales, data and medical affairs solutions to the Australian healthcare industry. ASX:FFC

合作联系

在 The iQ Group Global, 我们创建通向边缘的新路径 人类的发现。

Dr. George Syrmalis Group Chief Executive Officer

Unico Lan

Group Director, APAC

Unico Lan

Group Director, APAC

Adv Dip. FP, BCom, MIntBus With over 15 years’ experience in managing growth in financial markets, Unico has developed excellent relationship management skills with affluent clients, referral partners, investment teams, product teams, treasury and compliance. Unico ensures strong growth and meaningful outcomes – analyzing and identifying risk, as well as ensuring compliance. Prior in joining The iQ Group Global, Unico held senior leadership roles with various highly reputable wealth management organizations both in Australia and China, including within Citibank Australia. One word for iQ – Futurist

Lei Xu

Director, Corporate Finance and Advisory

Lei Xu

Director, Corporate Finance and Advisory

BSc(Acc), MSc(Mgt), FCCA, MBA(Exec) As Director, Corporate Finance and Advisory, Lei is responsible for structuring the equity investment offerings for capital raising through equity capital markets. Also, Lei works closely with The Group’s capital access and corporate advisory functions to create structured financial instruments for funding the development of novel biotech assets. Lei holds an MBA from AGSM, and is Fellow of the Association of Chartered Certified Accountants. Lei previously served as Director of APAC for The iQ Group Global. One word to describe iQGG – Intelligence

Alan Wong

Head Private Wealth Relationship Manager, APAC

Alan Wong

Head Private Wealth Relationship Manager, APAC

B.Ec. With 9 years’ experience in the wealth management sector, particularly in the finance and biotech industry, Alan has developed professional management skills with high net worth clients. Alans’ background in equity, fixed income, hybrid securities, managed and structured investment and foreign exchange markets, gives him the tools to market a number of financial products to current and existing investors. As the Head of Relationship Management in the APAC private wealth team, Alan is responsible for providing investment strategies and solutions to high net worth individuals within the APAC region. One word to describe iQGG – Breakthrough

Dr. Parisa Hesami

Scientific Advisor

Dr. Parisa Hesami

Scientific Advisor

PhD, DVM As The iQ Group Global’s scientific and life sciences expert, Parisa leads the analysis and reporting for The Group’s scientific and medical communications. With more than 10 years’ experience in the life science sector in biotech and medical devices, Parisa uses her commercial and academic expertise to demystify and educate audiences about our world-class technologies, and provide clinical insight for all audiences of The Group. Parisa is particularly passionate about bridging the gap between science and business through educating investors about the drug development lifecycle, and the essential role early stage biotechnology plays in creating the medicines of tomorrow. Parisa holds a PhD in Biotechnology from the Queensland University of Technology, and completed a Doctor of Veterinary Medicine (DVM) and a post graduate diploma in Marketing and Management. One word to describe iQGG – Passionate

Ozel Djemal

Investor Engagement Manager

Ozel Djemal

Investor Engagement Manager

At The iQ Group Global, Ozel is responsible for engaging and managing the relationship with potential and existing investors who are looking for new and innovative opportunities in the biotechnology investment market. With 18 years’ experience in relationship management, Ozel is passionate about building long term relationships with individuals and is a dedicated professional focusing on customer engagement and relationship management. Having previously worked in the luxury automotive and technology industries, Ozel’s unique experience has led him to mastering skills in high-end competitive sales and elite management positions. One word to describe iQGG – Innovative

与团队联系

Are you a sophisticated investor?*